Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.

Tas F., Erturk K.

Japanese journal of clinical oncology, vol.51, pp.873-878, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 51
  • Publication Date: 2021
  • Doi Number: 10.1093/jjco/hyab031
  • Journal Name: Japanese journal of clinical oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Page Numbers: pp.873-878
  • Keywords: melanoma, stage III, mitotic rate, node-positive, AMERICAN JOINT COMMITTEE
  • Istanbul University Affiliated: Yes

Abstract

Background: Stage III melanoma is a heterogenous disease, and the number of tumor-involved lymph nodes is the most significantly unfavorable prognostic indicator for relapse and outcome. The aim of this study is to investigate the possible effects of the various clinicopathological factors on the course of node-positive stage III disease.